Soluble angiotensin-converting enzyme 2 as a prognostic biomarker for disease progression in patients infected with SARS-CoV-2

Noelia Diaz Troyano, Pablo Gabriel Medina, Stephen Weber, Martin Klammer, Raquel Barquin-DelPino, Laura Castillo-Ribelles, Angels Esteban, Manuel Hernández-González, Roser Ferrer-Costa, Tomas Pumarola, Francisco Rodriguez Frias
doi: https://doi.org/10.1101/2021.10.13.21264901

Article usage

Article usage: October 2021 to August 2025

AbstractFullPdf
Oct 20218507132
Nov 2021190233
Dec 20219234
Jan 20224057
Feb 20225535
Mar 2022300777
Apr 2022106134
May 202278016
Jun 202278023
Jul 20223924
Aug 20223936
Sep 20224708
Oct 20225417
Nov 20223107
Dec 20222218
Jan 202317110
Feb 20232055
Mar 20232134
Apr 202333118
May 202321112
Jun 2023842
Jul 20231115
Aug 20232499
Sep 20231549
Oct 2023922
Nov 2023301010
Dec 20231606
Jan 20241956
Feb 20241832
Mar 202420010
Apr 20241137
May 20241433
Jun 20241745
Jul 20241117
Aug 202420211
Sep 2024281014
Oct 20242223
Nov 202412214
Dec 20241616
Jan 202514516
Feb 2025292612
Mar 202558527
Apr 202526115
May 2025261114
Jun 202560327
Jul 2025442018
Aug 2025524
Back to top
Posted March 23, 2022.
Download PDF
Data/Code
Email
Soluble angiotensin-converting enzyme 2 as a prognostic biomarker for disease progression in patients infected with SARS-CoV-2
Noelia Diaz Troyano, Pablo Gabriel Medina, Stephen Weber, Martin Klammer, Raquel Barquin-DelPino, Laura Castillo-Ribelles, Angels Esteban, Manuel Hernández-González, Roser Ferrer-Costa, Tomas Pumarola, Francisco Rodriguez Frias
medRxiv 2021.10.13.21264901; doi: https://doi.org/10.1101/2021.10.13.21264901
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area